Related Experiment Video
Updated: Jun 3, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Financial conflicts of interest in economic analyses in oncology
Sekwon Jang1, Young Kwang Chae, Navneet S Majhail
1Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, 55455, USA.
Background:
Financial conflicts of interest can influence biomedical research. Using data from the American Society of Hematology and the American Society of Clinical Oncology annual meetings, we evaluated the frequency and influence of financial conflicts of interest on economic analyses in oncology.
Methods:
We systematically searched for economic analyses among American Society of Hematology (2006 to 2008) and American Society of Clinical Oncology (2004 to 2008) annual meeting abstracts. Information was collected on the presence and type of conflict of interest, type of economic analysis, health technology assessed, and author affiliations. To evaluate the influence of conflicts of interest on study results, the abstracts were categorized into 3 groups based on whether the study conclusions directly supported, indirectly supported, or did not support the sponsor's product.
Results:
Some financial conflicts of interest were present in 236 of 356 (66%) abstracts of economic analyses, which were submitted for presentation at these meetings. Among economic analyses with a conflict of interest, the conclusions of 138 (59%) studies directly supported the sponsor's product. Another 74 (31%) studies with a conflict of interest indirectly supported the sponsor's product.
Conclusions:
Financial conflicts of interest are prevalent in economic analyses presented at major oncology meetings. The majority of studies with any financial conflict of interest directly or indirectly support the sponsor's product.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Cancer Survival Analysis
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
